154 related articles for article (PubMed ID: 37974781)
1. Pathogenesis Analysis of Salivary Gland Tumors Through the Expression of Programmed Death-Ligand 1 (PD-L1).
Muna AI; Surya MEK; Margaretha M; Kosasih J; Syafriadi M
Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3098-3102. PubMed ID: 37974781
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.
Scarini JF; de Lima-Souza RA; Lavareze L; Ribeiro de Assis MCF; Damas II; Altemani A; Egal ESA; Dos Santos JN; Bello IO; Mariano FV
Front Oral Health; 2023; 4():942604. PubMed ID: 37138857
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
5. CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands.
Shamloo N; Taghavi N; Yazdani F; Shalpoush S; Ahmadi S
Dent Res J (Isfahan); 2018; 15(5):361-366. PubMed ID: 30233657
[TBL] [Abstract][Full Text] [Related]
6. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
7. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors.
Akai A; Yamamura Y; Nonaka M; Yoshihara T
Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743
[TBL] [Abstract][Full Text] [Related]
8. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
9. Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.
Covinsky M; Cai Z; Ambelil M; Liu J; Zhu H
Head Neck Pathol; 2018 Mar; 12(1):82-88. PubMed ID: 28589437
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 and PD-L2 Expression in Different Tumor Stages and Types of Malignant Salivary Gland Neoplasms: A Single-center Experience.
Leaf Flag B; Cam I; Civriz AH; Tunce EB; Ozcan BC; Akyol YK; Deger HM; Vural C; Ozturk M
Appl Immunohistochem Mol Morphol; 2024 Jun; ():. PubMed ID: 38847110
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis.
Mariano FV; Egal ES; Pramio D; Fidalgo F; Sara É; Costa AF; de Oliveira Gondak R; Coletta RD; de Almeida OP; Kowalski LP; Victorino Krepischi AC; Altemani A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):322-31. PubMed ID: 27544395
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas.
Nakano T; Takizawa K; Uezato A; Taguchi K; Toh S; Masuda M
Oral Oncol; 2019 Mar; 90():30-37. PubMed ID: 30846173
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment.
Gerdabi S; Asadian F; Kiani R; Khademi B; Haghshenas MR; Erfani N
Head Neck Pathol; 2023 Mar; 17(1):178-192. PubMed ID: 36169795
[TBL] [Abstract][Full Text] [Related]
14. Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation.
Markkanen A; Aro K; Laury AR; Mäkitie AA; Haglund C; Atula T; Hagström J
Sci Rep; 2022 May; 12(1):9029. PubMed ID: 35637257
[TBL] [Abstract][Full Text] [Related]
15. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Fine Needle Aspiration Cytopathology in Salivary Gland Tumors under Milan System: Challenges, Misdiagnosis Rates, and Clinical Recommendations.
Huang YT; Ho CY; Ou CY; Huang CC; Lee WT; Tsai SW; Hsu HJ; Hung DS; Tsai CS; Fang SY; Tsai ST; Hsiao JR; Chang CC; Chen CC
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509612
[TBL] [Abstract][Full Text] [Related]
17. Soluble E-cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma.
Chen W; Ye S; Wang X; Qian J; Xia L; Tian Z
J Oral Pathol Med; 2023 Jan; 52(1):63-71. PubMed ID: 36445289
[TBL] [Abstract][Full Text] [Related]
18. Influence of p16 Protein Immunostaining on Histopathological Features of Pleomorphic Adenoma and Carcinoma ex- Pleomorphic Adenoma.
Magalhaes IA; Barbosa KC; Costa GAJ; Oliveira Filho OV; Da Silva Junior JE; Gonzaga Silva LF; Juaçaba SF; Sousa FB; Barros Silva PG
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3815-3824. PubMed ID: 38019239
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.
de Souza AA; Altemani A; de Araujo NS; Texeira LN; de Araújo VC; Soares AB
Clin Pathol; 2019; 12():2632010X19873384. PubMed ID: 31598607
[TBL] [Abstract][Full Text] [Related]
20. Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma.
de Lima-Souza RA; Scarini JF; Lavareze L; Emerick C; Crescencio LR; Domingues RR; Paes Leme AF; Mariz BALA; Bastos DC; Machado RA; Tincani AJ; Del Negro A; Chone CT; Kowalski LP; Egal ESA; Altemani A; Mariano FV
Oral Dis; 2023 Apr; 29(3):1017-1027. PubMed ID: 34902207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
